SCHEMBL6166699

SCHEMBL6166699

Cc1nn(CCO)c2c1C(=O)CC(C)C2

nearest known ligand 0.61

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
HTT P42858 3/20 0.61
TSHR P16473 3/20 0.34
CSNK2A2 P19784 3/20 0.33
CSNK2B P67870 3/20 0.33
CSNK2A1 P68400 3/20 0.33
ABCG2 Q9UNQ0 3/20 0.33
BUB1 O43683 1/20 0.32
ALDH1A1 P00352 5/20 0.32
MAPT P10636 1/20 0.32
HPGD P15428 1/20 0.32
CSNK2A3 Q8NEV1 1/20 0.32
MAPK1 P28482 3/20 0.31
LMNA P02545 1/20 0.31
HDAC1 Q13547 1/20 0.31
HDAC6 Q9UBN7 1/20 0.31
MAPK8 P45983 1/20 0.30
OPRM1 P35372 1/20 0.30
KMT2A Q03164 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6166391 0.83 HTT (0.42) HTTCSNK2A2CSNK2BCSNK2A1ABCG2
SCHEMBL6164263 0.82 HTT (0.41) HTTCSNK2A2CSNK2BCSNK2A1ABCG2
SCHEMBL6164302 0.82 HTT (0.57) HTT
SCHEMBL6165102 0.82 HTT (0.41) HTTCSNK2A2CSNK2BCSNK2A1ABCG2
SCHEMBL6163497 0.81 HTT (0.40) HTTTSHRCSNK2A2CSNK2BCSNK2A1
SCHEMBL6167888 0.80 HTT (0.39) HTTCSNK2A2CSNK2BCSNK2A1ABCG2
SCHEMBL6166292 0.78 HTT (0.36) HTTTSHRCSNK2A2CSNK2BCSNK2A1
SCHEMBL6165167 0.76 HTT (1.00) HTTTSHRCSNK2A1BUB1ALDH1A1
SCHEMBL6163859 0.74 HTT (0.35) HTTCSNK2A2CSNK2BCSNK2A1ABCG2
SCHEMBL6165525 0.73 HTT (0.61) HTTHDAC1HDAC6OPRM1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1177185-B1 4, 5, 6, 7-TETRAHYDROINDAZOLE DERIVATIVES AS ANTITUMOR AGENTS PHARMACIA ITALIA SPA (IT) 2005-04-20 EP disclosed
US-6716856-B1 CELL PROLIFERATIVE DISORDERS OR ALZHEIMER'S DISEASE; REDUCED TOXICITY; CDK/CYCLIN KINASE INHIBITORY ACTIVITY PHARMACIA & TUBJOHN SPA (IT) 2004-04-06 US disclosed